Development of precision medicine approaches based on inter-individual variability of BCRP/ABCG2
Open Access
- 1 July 2019
- journal article
- review article
- Published by Elsevier in Acta Pharmaceutica Sinica B
- Vol. 9 (4) , 659-674
Abstract
No abstract availableKeywords
Funding Information
- National Institute of General Medical Sciences (R01GM118367)
This publication has 133 references indexed in Scilit:
- Intestinal Expression of Mouse Abcg2/Breast Cancer Resistance Protein (BCRP) Gene Is under Control of Circadian Clock-activating Transcription Factor-4 PathwayJournal of Biological Chemistry, 2012
- RNA-Seq Reveals Different mRNA Abundance of Transporters and Their Alternative Transcript Isoforms During Liver DevelopmentToxicological Sciences, 2012
- Eltrombopag increases plasma rosuvastatin exposure in healthy volunteersBritish Journal of Clinical Pharmacology, 2011
- MicroRNA-328 Negatively Regulates the Expression of Breast Cancer Resistance Protein (BCRP/ABCG2) in Human Cancer CellsMolecular Pharmacology, 2009
- Sunitinib (Sutent, SU11248), a Small-Molecule Receptor Tyrosine Kinase Inhibitor, Blocks Function of the ATP-Binding Cassette (ABC) Transporters P-Glycoprotein (ABCB1) and ABCG2Drug Metabolism and Disposition, 2009
- Association of the ABCG2 C421A polymorphism with prostate cancer risk and survivalBJU International, 2008
- Major SNP (Q141K) Variant of Human ABC Transporter ABCG2 Undergoes Lysosomal and Proteasomal DegradationsPharmaceutical Research, 2008
- Drug transporters: recent advances concerning BCRP and tyrosine kinase inhibitorsBritish Journal of Cancer, 2008
- Histone Modifications at the ABCG2 Promoter following Treatment with Histone Deacetylase Inhibitor Mirror Those in Multidrug-Resistant CellsMolecular Cancer Research, 2008
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998